SBS BVS
08:30-09:00 Registration, welcome and coffee
09:00-09:10 Introduction: more or less treatment for breast cancer?
Prof. dr. H. Wildiers, UZ Leuven
PRE-TREATMENT EVALUATION
09:10-09:30 Whole body diffusion MRI needed for metastases screening?
Dr S. Pans, UZ Leuven
09:30-10:00
Breast pathology: Multigene expression profiling always needed in clinical high risk
ER positive, HER 2 negative cases?
Prof. dr. M. Piccart, Institut Jules Bordet Bruxelles
DE-ESCALATION IN LOCAL TREATMENT?
10:00-10:25 Metastatic sentinel node: is axillary clearance avoidable?
Dr. P. Cusumano, CHC de Liège
10:30-11:00 Coffee break and SBS - BVS General Assembly
11:00-11:25
Local tumor relapse after breast conservative surgery and adjuvant radiotherapy:
place for a second conservative treatment?
Prof. dr. W. Tjalma, UZ Antwerpen
11:25-11:50 Partial instead of whole breast radiation?
Dr. V. Remouchamps, CHU UCL Namur, Site Ste Elisabeth
DE-ESCALATION OF SYSTEMIC TREATMENT?
11:50-12:15
Do all patients with ER positive early breast cancer need 10 years of antihormonal
therapy?
Prof. dr. P. Neven, UZ Leuven
12:15-12:40 End of chemotherapy in ER-pos HER-2 neg breast cancer?
Prof. dr. G. Jerusalem, CHU de Liège
12:45 Reception with refreshments
The SBS-BVS board : C.Van Ongeval (President 2016-2017)
V.Bleret, J.Collignon, P. Cusumano, F. Duhoux, G.Floris, P.Neven, J.C.Schobbens, M.Van Goethem,
H.Wildiers
www.seno.be